“Kegels In A Bottle”: Preliminary Results Of A Selective Androgen Receptor Modulator For The Treatment Of SUI - Kenneth M. Peters

(Lecture and Discussion in 14 min.) 

Kenneth Peters, MD. presents a proof of concept study first discussed at the International Continence Society meeting in September 2017.  Ken discusses the background of Enobosarm: and the Biology-Driven Selectivity.  He discusses the selective androgen receptor modulators (SARM) biology vs. steroidal androgens and that Enobosarm Increases Pelvic Floor Muscle Weight.  His focus for the discussion are the results of a proof of concept study: Enobosarm as a Treatment for Stress Urinary Incontinence in Women.  After the presentation, there is a brief discussion between Ken Peters and Diane Newman.  

GTx Announces Positive Results from Enobosarm Phase 2 Proof-of-Concept Clinical Trial in Women with Stress Urinary Incontinence

Biograpies:

Kenneth M. Peters, MD., Peter & Florine Ministrelli Distinguished Chair in Urology, graduated from the Case Western Reserve University School of Medicine and completed Urology residency and fellowship training at Beaumont Hospital.  Dr. Peters specializes in the treatment of voiding dysfunction and female urology. He is an NIH-funded researcher and has performed innovative studies on neuromodulation to treat voiding dysfunction, lumbar to sacral nerve re-routing to restore voiding in spina bifida patients, and adult human stem cell injection for stress urinary incontinence. Oakland University William Beaumont School of Medicine Royal Oak, Michigan.  

Diane K. Newman, DNP, FAAN, BCB-PMD, is Research Investigator Senior and Adjunct Associate Professor of Urology in Surgery, Perelman School of Medicine, Univeristy of Pennsuylvania. Dr. Newman is Co-Director of the Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Medical Center, in Philadelphia.